CTOs on the Move

Esperance Pharmaceuticals

www.esperancepharma.com

 
Esperance Pharmaceuticals, Inc. is developing a new class of targeted oncology products that selectively kill cancer cells without harming normal cells. Targeting occurs through binding to specific receptors on the cancer cell surface. The novel product candidates destroy dividing and non-dividing cancer cells including those known to be resistant to chemotherapeutics.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Funding

Esperance Pharmaceuticals raised $40M on 03/30/2016

Similar Companies

Health Network

Health Network is a Cranston, RI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

X-37

X-37 is a pharmaceutical discovery and development company

SENN CHEMICALS

SENN CHEMICALS is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Qosina

Qosina is one of the leading medical device component suppliers of OEM components to medical and pharmaceutical industries. Explore our products today.

Encore Dermatology

Headquartered in Malvern, Pennsylvania, Encore Dermatology is a privately held fully integrated dermatology company with a mission committed to delivering innovative prescription therapies and medical devices to dermatologists focusing on customer service and improving the quality-of-life of patients.